To further strengthen the supervision and inspection over sterile and implantable medical devices (including high-value medical consumables), implement the requirements of the Notice of the General Office of the State Council on the Issuance of the Reform Plan for Governance over High-value Medical Consumables (State Council General Office [2019] No. 37), fully implement the corporate principal responsibility and ensure the safety and effectiveness of medical devices, taking into account the arrangement for medical device supervision in 2020, as well as the prevention and control of the COVID-19 epidemic situation, on April 14, 2020, NMPA issued the Notice on Strengthening the Supervision and Inspection of Sterile and Implantable Medical Devices, requiring the Medical Products Administration Departments of all provinces, autonomous regions, municipalities directly under the central government and the Xinjiang Production and Construction Corps to further strengthen the supervision and inspection of sterile and implantable medical devices (including high-value medical consumables) .